Indivior PLC
D

INDV

34.470
USD
-0.89
(-2.52%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
59,016
الربح لكل سهم
3
العائد الربحي
-
P/E
12
حجم السوق
4,068,560,765
نظرة عامة
أصول ذات صلة
AXP
AXP
D
American Express Company
313.14
-11.88(-3.65%)
313.34+0.20(+0.07%)
BAC
BAC
D
بنك أوف أمريكا
50.565
-0.535(-1.05%)
50.650+0.085(+0.17%)
COF
COF
D
Capital One Financial
201.320
-2.050(-1.01%)
200.310-1.010(-0.50%)
JPM
JPM
D
جي بي مورجان تشيس
331.57
-4.93(-1.47%)
331.85+0.28(+0.08%)
MA
MA
D
ماستركارد
623.47
-9.42(-1.49%)
623.30-0.17(-0.03%)
MS
MS
D
Morgan Stanley
179.470
-4.520(-2.46%)
179.550+0.080(+0.04%)
PYPL
PYPL
D
PayPal Holdings
57.000
-0.535(-0.93%)
SCHW
SCHW
D
Charles Schwab Corp (The)
90.600
-0.830(-0.91%)
90.790+0.190(+0.21%)
V
V
D
فيزا
407.94
-6.34(-1.53%)
408.05+0.11(+0.03%)
المزيد

العنوان: Indivior Pharmaceuticals Inc.

القطاع: الرعاية الصحية
الصناعة: Drug Manufacturers - Specialty & Generic
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).